In this issue:
Circulating tumour cell count and OS in mHSPC
Radiotherapy timing and long-term HRQoL
Infection risk between enzalutamide and abiraterone
Evaluation of margins during radical prostatectomy
No, short-term, or long-term ADT after radical prostatectomy
Clinically significant prostate cancer with MRI lesions visible on TRUS
Prior local therapy effect on first-line apalutamide
Long-term outcomes of PSMA-PET imaging
Stockholm3 risk score for prostate cancer detection
Effects of bony pelvic and prostate dimensions on surgical difficulty
Please login below to download this issue (PDF)